The important role of brigatinib/brigatinib in the treatment of non-small cell lung cancer

Brigatinib/Brigatinib (Brigatinib) is an important targeted therapy for ALK-positive non-small cell lung cancer. Its core mechanism is to effectively control the growth and spread of tumors by precisely inhibiting the activity of the ALK protein. However, non-small cell lung cancer is a highly complex disease, and its treatment path usually needs to be carefully customized based on multiple factors such as the patient's specific condition, cancer stage, and genetic mutations.

Among the many factors that affect the efficacy of treatment, the multiple gene mutations that may exist in non-small cell lung cancer are particularly critical. For example, ALK fusion gene mutations are one of them, but other types of cancer-causing mutations may also exist. These mutations sometimes cause tumors to become resistant to specific treatments, affecting the likelihood of cure. Although brigatinib is excellent at inhibiting the activity of ALK fusion genes, it may not have the same efficacy against other types of mutations.

When using brigatinib, patients should strictly follow the doctor's instructions and ensure that the daily dosage and medication time are consistent with the doctor's instructions. Typically, brigatinib is taken as an oral tablet, taken once daily, with or without food, depending on individual circumstances. In some cases, doctors may advise patients to start with a lower dose and gradually increase it over a week of treatment.

It is worth mentioning that effective treatment of lung cancer often requires the comprehensive application of multiple methods, including but not limited to surgery, radiotherapy and chemotherapy. Although brigatinib is an important treatment, the best therapeutic effect usually needs to be achieved through organic combination with other treatments. This comprehensive treatment strategy not only improves the effectiveness of treatment, but also helps to further prolong patient survival and improve quality of life.